Articles by Asher Jones

A long-term study finds that moon cycles and menstrual cycles align at certain times of women’s lives, shedding new light on the full moon and menstrual cycle relationship.

More and more people are traveling around the world to watch the luminous displays of fireflies, but tourism-related light pollution and habitat degradation threaten to snuff out the insects at some locations.  

A tidy-up of a New Zealand storage room led to the sale of naming rights for three new-to-science Galápagos Islands species.

Whether the galls that aphids make on witch hazel leaves are red or green is associated with a gene expressed in the insects’ salivary glands.

Meet some of the people featured in the April 2021 issue of The Scientist.

A mutant protein called Siglec-XII may promote carcinoma progression in humans, but inactivation of its gene seems to avoid the problem, according to a study.

Altered gut microbiome composition in obese mice and human patients is linked with severity of disease after bone marrow transplantation, a study found.

A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.

Researchers turned white blood cells called neutrophils into drug-smuggling “neutrobots,” which penetrated the blood-brain barrier to treat brain cancer in mice.

A bipartisan bill aims to increase the National Science Foundation’s budget over the next five years and form a new technology directorate.

More-accurate predictions of the severity of an upcoming grass pollen season based on rainfall and temperature could help allergy sufferers manage their symptoms.

A noninvasive saliva test accurately identified concussions in a study of hundreds of rugby players.

Neural connections in the mouse neocortex can release multiple packages of neurotransmitters per electrical impulse, a study finds.

Synapses in the mouse neocortex can release multiple packages of neurotransmitters, suggesting that connection strength is more flexible than previously thought.

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.